Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip L Herschman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Psychiatry Journal|May 20, 2014
The continuing care model of substance use treatment: what works, and when is "enough," "enough?"Steven L Proctor, Philip L Herschman
Journal of Addiction Medicine|September 11, 2018
Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature DischargeSteven L Proctor, Autumn Birch, Philip L Herschman
The American Journal of Drug and Alcohol Abuse|May 31, 2017
Importance of short-term continuing care plan adherence on long-term outcomes among patients discharged from residential substance use treatmentSteven L Proctor, Jaclyn L Wainwright, Philip L Herschman
Journal of Substance Abuse Treatment|July 31, 2017
Patient adherence to multi-component continuing care discharge plansSteven L Proctor, Jaclyn L Wainwright, Philip L Herschman
Substance Use & Misuse|October 27, 2018
The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance TreatmentSteven L Proctor, Philip L Herschman, Ronnie Lee, et al.
Journal of Substance Abuse Treatment|December 27, 2016
AiRCare: A naturalistic evaluation of the effectiveness of a protracted telephone-based recovery assistance program on continuing care outcomesSteven L Proctor, Jaclyn L Wainwright, Philip L Herschman, et al.
Experimental and Clinical Psychopharmacology|July 29, 2014
A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite studySteven L Proctor, Amy L Copeland, Albert M Kopak, et al.
The American Journal on Addictions|February 7, 2015
Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-upDouglas L Leslie, William Milchak, David R Gastfriend, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Psychiatry Journal|May 20, 2014
The continuing care model of substance use treatment: what works, and when is "enough," "enough?"Steven L Proctor, Philip L Herschman
Journal of Addiction Medicine|September 11, 2018
Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature DischargeSteven L Proctor, Autumn Birch, Philip L Herschman
The American Journal of Drug and Alcohol Abuse|May 31, 2017
Importance of short-term continuing care plan adherence on long-term outcomes among patients discharged from residential substance use treatmentSteven L Proctor, Jaclyn L Wainwright, Philip L Herschman
Journal of Substance Abuse Treatment|July 31, 2017
Patient adherence to multi-component continuing care discharge plansSteven L Proctor, Jaclyn L Wainwright, Philip L Herschman
Substance Use & Misuse|October 27, 2018
The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance TreatmentSteven L Proctor, Philip L Herschman, Ronnie Lee, et al.
Journal of Substance Abuse Treatment|December 27, 2016
AiRCare: A naturalistic evaluation of the effectiveness of a protracted telephone-based recovery assistance program on continuing care outcomesSteven L Proctor, Jaclyn L Wainwright, Philip L Herschman, et al.
Experimental and Clinical Psychopharmacology|July 29, 2014
A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite studySteven L Proctor, Amy L Copeland, Albert M Kopak, et al.
The American Journal on Addictions|February 7, 2015
Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-upDouglas L Leslie, William Milchak, David R Gastfriend, et al.
Pageof 1